Gunes Sezgin, Yalaz Mehmet, Sozmen Eser, Koroglu Ozge Altun, Kultursay Nilgun
Department of Pediatrics, Division of Neonatology, Ege University Faculty of Medicine, Izmir, Turkey.
Department of Biochemistry, Ege University Faculty of Medicine, Izmir, Turkey.
Pediatr Int. 2015 Jun;57(3):414-21. doi: 10.1111/ped.12532. Epub 2015 Jan 16.
The aim of this study was to investigate the relationship between plasma chitotriosidase activity, an inflammatory protein secreted mainly from macrophages, and neonatal morbidity and mortality in premature infants.
Cord blood chitotriosidase activity was studied in healthy control infants (53 term, group 1; 26 late preterm [33-37 gestational weeks], group 2) and 35 preterm infants (≤ 32 weeks; group 3). In group 3, consecutive samples at 3 h, 24 h, 72 h, 7 days, 14 days, and 36 weeks after conception were also analyzed. Group 3 was also evaluated for mortality, respiratory treatment and bronchopulmonary dysplasia (BPD), patent ductus arteriosus (PDA), intraventricular hemorrhage (IVH) and retinopathy of prematurity (ROP) and necrotizing enterocolitis (NEC).
Cord blood chitotriosidase activity was positively correlated with gestational age and birthweight. SNAPPE-II score was correlated with chitotriosidase activity at 24 h. Consecutive chitotriosidase activity for group 3 was non-significantly higher in infants who died in the early neonatal period. Higher chitotriosidase activity was observed in mechanically ventilated infants than infants treated with non-invasive assisted ventilation. BPD, PDA, IVH and ROP, but not NEC, were related to higher chitotriosidase activity, being significant at some of the time points.
Neonatal stress such as invasive ventilation may create a risk for the development of BPD, PDA, IVH, and ROP by increasing macrophage activation in preterm infants as reflected in the higher chitotriosidase activity. High chitotriosidase activity may also be associated with disease severity and mortality.
本研究旨在探讨血浆壳三糖苷酶活性(一种主要由巨噬细胞分泌的炎症蛋白)与早产儿新生儿发病率和死亡率之间的关系。
对健康对照婴儿(53例足月儿,第1组;26例晚期早产儿[孕33 - 37周],第2组)和35例早产儿(≤32周;第3组)的脐血壳三糖苷酶活性进行研究。在第3组中,还分析了受孕后3小时、24小时、72小时、7天、14天和36周时的连续样本。对第3组婴儿的死亡率、呼吸治疗及支气管肺发育不良(BPD)、动脉导管未闭(PDA)、脑室内出血(IVH)、早产儿视网膜病变(ROP)和坏死性小肠结肠炎(NEC)也进行了评估。
脐血壳三糖苷酶活性与胎龄和出生体重呈正相关。SNAPPE - II评分与24小时时的壳三糖苷酶活性相关。第3组中,早期新生儿死亡的婴儿连续壳三糖苷酶活性略高,但无统计学意义。机械通气婴儿的壳三糖苷酶活性高于无创辅助通气治疗的婴儿。BPD、PDA、IVH和ROP(而非NEC)与较高的壳三糖苷酶活性有关,在某些时间点具有统计学意义。
侵入性通气等新生儿应激可能通过增加早产儿巨噬细胞活化,导致BPD、PDA、IVH和ROP的发生风险增加,这在较高的壳三糖苷酶活性中得以体现。高壳三糖苷酶活性也可能与疾病严重程度和死亡率相关。